Leading Healthy Eating and Activity Promotion Program

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-89
SponsorUniversity of Alabama at Birmingham

About this trial

The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Between the ages of 18 and 89

English speaking

Resident of Birmingham area or surrounding community

History of any type of cancer or the friend or family with of a cancer survivor

Disqualifiers

Serious difficulty hearing

History of dementia or organic brain syndrome

On primary treatment for cancer

No other other medical, psychological, or social characteristic that would interfere with participation in evaluation

Trial design

Design model

Single group

Treatments tested in this trial

  • LEAP Program

    Behavioral

    Combines a publicly available website with educational materials related to healthy eating, regular exercise, and a healthy body weight. Interested community members can also join optional in person community-based events that reinforce the educational material on the website.

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: Program participantsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Weekly intake of vegetables, fruit, and sugar sweetened beverages

Each participant reports the average times per week they eat vegetables, eat fruit, and drink sugar sweetened beverages

Time frame
Baseline, 12 weeks
2

Average time spent doing physical activity based on accelerometer

Measuring physical activity from one-week of wearing an accelerometer

Time frame
Baseline, 12 weeks
3

Body mass index (BMI)

Trained research staff will measure height using portable stadiometer (baseline only; no shoes) and weight using portable calibrated scale (light clothing without shoes) to calculate BMI (weight in kg/height in meters squared)

Time frame
Baseline, 12 weeks

Secondary outcomes

1

Overall quality of life score

self reported survey to collect data about physical, mental, and social health on a scale of 1 to 5 with 5 being excellent and 1 being poor

Time frame
Baseline, 12-weeks
2

Self-report physical activity

Participants report time per day or week doing moderate intensity physical activity, doing vigorous intensity physical activity, walking, and sitting.

Time frame
Baseline, 12 weeks
3

Evaluation of the LEAP Program

Participants complete a survey about the LEAP Program activities they did and feedback on the program

Time frame
12 weeks
4

Physical performance

Number of times a participant can stand up from a chair in 30 seconds and the time it takes for a participant to stand up from a chair, walk 10 feet, and return to sit in the chair

Time frame
Baseline, 12 weeks

Other outcomes

1

Participant demographic characteristics

Participants complete a survey asking about demographic characteristics (age, sex, race, residence, education, income, employment, etc.)

Time frame
Baseline
2

Participant medical and lifestyle characteristics

Participants complete a survey about their medical (cancer history, comorbidities), and lifestyle (alcohol, smoking) characteristics.

Time frame
Baseline, 12 weeks
3

Food access

Participants complete a survey asking about the availability of low-fat foods, vegetables, and fruits in their neighborhood

Time frame
Baseline, 12 weeks
4

Neighborhood walkability

Participants complete a survey asking about how easy it is to walk to places in their neighborhood.

Time frame
Baseline, 12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

National Cancer Institute (NCI)

Collaborator